Last reviewed · How we verify
NCT03636607
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma
NA trial testing PET/CT dynamic scan in Positron-Emission Tomography. Withdrawn.
31 December 2025
Quick facts
| Lead sponsor | Fifth Affiliated Hospital, Sun Yat-Sen University |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Start date | 13 June 2018 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- PET/CT dynamic scan
Conditions studied
- Positron-Emission Tomography — all drugs for Positron-Emission Tomography →
- Carcinoma, Hepatocellular — all drugs for Carcinoma, Hepatocellular →
Sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University
Who can join
Adults 18 to 65, any sex, with Positron-Emission Tomography or Carcinoma, Hepatocellular. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to make up for this gap by performing a dynamic scan of 18F-FDG PET/CT on newly diagnosed patients with liver cancer. The lesions and/or metastases are performed for biopsy. Pathological and genomic studies are performed. The differences between tumor images and tissues are compared at the same time. 18F-FDG PET/CT dynamic imaging is explored in primary liver cancer metastases for the diagnostic value.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03636607
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PET/CT dynamic scan
Trials testing the same drug.
- NCT03679936 — Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging an · unknown
Other recruiting trials for Positron-Emission Tomography
Currently open trials in the same condition.
- NCT06387381 — 68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease · EARLY_PHASE1 · recruiting
- NCT06203574 — Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors · NA · recruiting
- NCT05873777 — 68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG · NA · recruiting
- NCT05610098 — Gene Expression Profiles in Spinal Tuberculosis. · recruiting
- NCT04416165 — Comparison of FDG and FAPI in Patients With Various Types of Cancer · NA · recruiting
Other Fifth Affiliated Hospital, Sun Yat-Sen University trials
Trials by the same sponsor.
- NCT06079931 — The Efficacy of Babaodan Capsules in Preventing Radiation Pneumonia · Phase 2 · unknown
- NCT06525025 — Building a Traditional Chinese Medicine Clinical Diagnosis and Treatment Database · not yet recruiting
- NCT06060782 — Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine · Phase 1 · recruiting
- NCT06220552 — The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma · Phase 2 · recruiting
- NCT06147947 — Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03636607 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fifth Affiliated Hospital, Sun Yat-Sen University
- Last refreshed: 24 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03636607.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing